These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36869838)

  • 1. Airway delivery of Streptococcus salivarius is sufficient to induce experimental pulmonary hypertension in rats.
    Zhang C; Zhang T; Xing Y; Lu W; Chen J; Luo X; Wu X; Liu S; Chen L; Zhang Z; Zhou D; Lin Z; Chen Y; Xiong M; Yuan JX; Yang K; Wang J
    Br J Pharmacol; 2023 Aug; 180(16):2102-2119. PubMed ID: 36869838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension.
    Christou H; Reslan OM; Mam V; Tanbe AF; Vitali SH; Touma M; Arons E; Mitsialis SA; Kourembanas S; Khalil RA
    Am J Physiol Lung Cell Mol Physiol; 2012 May; 302(9):L875-90. PubMed ID: 22287610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiome and metabolome dysbiosis of the gut-lung axis in pulmonary hypertension.
    Chen J; Zhou D; Miao J; Zhang C; Li X; Feng H; Xing Y; Zhang Z; Bao C; Lin Z; Chen Y; Yuan JX; Sun D; Yang K; Wang J
    Microbiol Res; 2022 Dec; 265():127205. PubMed ID: 36202007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota modification suppresses the development of pulmonary arterial hypertension in an SU5416/hypoxia rat model.
    Sanada TJ; Hosomi K; Shoji H; Park J; Naito A; Ikubo Y; Yanagisawa A; Kobayashi T; Miwa H; Suda R; Sakao S; Mizuguchi K; Kunisawa J; Tanabe N; Tatsumi K
    Pulm Circ; 2020; 10(3):2045894020929147. PubMed ID: 32922743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.
    Bordenave J; Thuillet R; Tu L; Phan C; Cumont A; Marsol C; Huertas A; Savale L; Hibert M; Galzi JL; Bonnet D; Humbert M; Frossard N; Guignabert C
    Cardiovasc Res; 2020 Mar; 116(3):686-697. PubMed ID: 31173066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case-Control Microbiome Study of Chronic Otitis Media with Effusion in Children Points at Streptococcus salivarius as a Pathobiont-Inhibiting Species.
    Jörissen J; van den Broek MFL; De Boeck I; Van Beeck W; Wittouck S; Boudewyns A; Van de Heyning P; Topsakal V; Van Rompaey V; Wouters I; Van Heirstraeten L; Van Damme P; Malhotra-Kumar S; Theeten H; Vanderveken OM; Lebeer S
    mSystems; 2021 Apr; 6(2):. PubMed ID: 33879499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SuHx rat model: partly reversible pulmonary hypertension and progressive intima obstruction.
    de Raaf MA; Schalij I; Gomez-Arroyo J; Rol N; Happé C; de Man FS; Vonk-Noordegraaf A; Westerhof N; Voelkel NF; Bogaard HJ
    Eur Respir J; 2014 Jul; 44(1):160-8. PubMed ID: 24791833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of treprostinil in the SU5416-hypoxia model of severe pulmonary arterial hypertension: haemodynamic benefits are not associated with improvements in arterial remodelling.
    Chaudhary KR; Deng Y; Suen CM; Taha M; Petersen TH; Mei SHJ; Stewart DJ
    Br J Pharmacol; 2018 Oct; 175(20):3976-3989. PubMed ID: 30098019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artemisinin and Its Derivate Alleviate Pulmonary Hypertension and Vasoconstriction in Rodent Models.
    Bao C; He Q; Wang H; Sun Y; Xu Y; Pan Y; Hu Y; Zheng S; Liang S; Luo A; Nahar T; Chen J; Tang H; Han Y
    Oxid Med Cell Longev; 2022; 2022():2782429. PubMed ID: 35757500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics Streptococcus salivarius 24SMB and Streptococcus oralis 89a interfere with biofilm formation of pathogens of the upper respiratory tract.
    Bidossi A; De Grandi R; Toscano M; Bottagisio M; De Vecchi E; Gelardi M; Drago L
    BMC Infect Dis; 2018 Dec; 18(1):653. PubMed ID: 30545317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure.
    Suen CM; Chaudhary KR; Deng Y; Jiang B; Stewart DJ
    Cardiovasc Res; 2019 Mar; 115(4):788-799. PubMed ID: 30357319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel rat model of pulmonary hypertension induced by mono treatment with SU5416.
    Chen Y; Kuang M; Liu S; Hou C; Duan X; Yang K; He W; Liao J; Zheng Q; Zou G; Chen H; Yan H; Chen J; Li Y; Zhou Y; Luo X; Jiang Q; Tang H; Lu W; Wang J
    Hypertens Res; 2020 Aug; 43(8):754-764. PubMed ID: 32472112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research on rat models of hypobaric hypoxia-induced pulmonary hypertension.
    Ma TT; Wang Y; Zhou XL; Jiang H; Guo R; Jia LN; Chang H; Gao Y; Yao XY; Gao ZM; Pan L
    Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3723-30. PubMed ID: 26502863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Sugen 5416/hypoxia mouse model of pulmonary hypertension revisited: long-term follow-up.
    Vitali SH; Hansmann G; Rose C; Fernandez-Gonzalez A; Scheid A; Mitsialis SA; Kourembanas S
    Pulm Circ; 2014 Dec; 4(4):619-29. PubMed ID: 25610598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paeoniflorin Ameliorates Chronic Hypoxia/SU5416-Induced Pulmonary Arterial Hypertension by Inhibiting Endothelial-to-Mesenchymal Transition.
    Yu M; Peng L; Liu P; Yang M; Zhou H; Ding Y; Wang J; Huang W; Tan Q; Wang Y; Xie W; Kong H; Wang H
    Drug Des Devel Ther; 2020; 14():1191-1202. PubMed ID: 32256050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of right coronary vascular dysfunction in severe pulmonary hypertensive rats using synchrotron radiation microangiography.
    Inagaki T; Pearson JT; Tsuchimochi H; Schwenke DO; Saito S; Higuchi T; Masaki T; Umetani K; Shirai M; Nakaoka Y
    Am J Physiol Heart Circ Physiol; 2021 Mar; 320(3):H1021-H1036. PubMed ID: 33481696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension.
    Rol N; de Raaf MA; Sun XQ; Kuiper VP; da Silva Gonçalves Bos D; Happé C; Kurakula K; Dickhoff C; Thuillet R; Tu L; Guignabert C; Schalij I; Lodder K; Pan X; Herrmann FE; van Nieuw Amerongen GP; Koolwijk P; Vonk-Noordegraaf A; de Man FS; Wollin L; Goumans MJ; Szulcek R; Bogaard HJ
    Cardiovasc Res; 2019 Feb; 115(2):432-439. PubMed ID: 30032282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-type natriuretic peptide does not attenuate the development of pulmonary hypertension caused by hypoxia and VEGF receptor blockade.
    Casserly B; Mazer JM; Vang A; Harrington EO; Klinger JR; Rounds S; Choudhary G
    Life Sci; 2011 Sep; 89(13-14):460-6. PubMed ID: 21820448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SU5416 plus hypoxia but not selective VEGFR2 inhibition with cabozantinib plus hypoxia induces pulmonary hypertension in rats: potential role of BMPR2 signaling.
    Sitapara R; Sugarragchaa C; Zisman LS
    Pulm Circ; 2021; 11(3):20458940211021528. PubMed ID: 34178306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired Pulmonary Arterial Vasoconstriction and Nitric Oxide-Mediated Relaxation Underlie Severe Pulmonary Hypertension in the Sugen-Hypoxia Rat Model.
    Christou H; Hudalla H; Michael Z; Filatava EJ; Li J; Zhu M; Possomato-Vieira JS; Dias-Junior C; Kourembanas S; Khalil RA
    J Pharmacol Exp Ther; 2018 Feb; 364(2):258-274. PubMed ID: 29212831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.